Connection
Robert McQueen to Omalizumab
This is a "connection" page, showing publications Robert McQueen has written about Omalizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.221 |
|
|
|
-
McQueen RB, Anderson KE, Levy JF, Carlson JJ. Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Valuable? Pharmacoeconomics. 2023 03; 41(3):321-327.
Score: 0.195
-
Campbell JD, McQueen RB, Briggs A. The "e" in cost-effectiveness analyses. A case study of omalizumab efficacy and effectiveness for cost-effectiveness analysis evidence. Ann Am Thorac Soc. 2014 Feb; 11 Suppl 2:S105-11.
Score: 0.026